Status
Conditions
Treatments
About
This is a single center, prospective biomarker study to evaluate serum levels of TWEAK and expression levels of TWEAK and Fn14 in muscle biopsies from patients with sarcopenia as well as healthy, physically active controls.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
To be eligible to participate in this study, all candidates must meet the following eligibility criteria at Baseline or at the time point specified in the individual eligibility criterion listed:
All Participants
Subjects with Sarcopenia
Healthy Controls
Exclusion criteria
Candidates will be excluded from study entry if any of the following exclusion criteria exist at Screening:
30 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal